Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children
2018-01-01 Sali, M; Buonsenso, D; D'Alfonso, P; De Maio, F; Ceccarelli, M; Battah, B; Palucci, I; Chiacchio, T; Goletti, D; Sanguinetti, M; Valentini, P; Delogu, G
Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: a prospective, observational study
2012-01-01 Garcovich, S; Ruggeri, A; D'Agostino, M; Ardito, F; De Simone, C; Delogu, G; Fadda, G.
PE_PGRS30 is required for the full virulence of Mycobacterium tuberculosis
2012-01-01 Iantomasi, Raffaella; Sali, Michela; Cascioferro, A; Palucci, Ivana; Zumbo, Antonella; Soldini, Silvia; Rocca, S; Greco, E; Maulucci, Giuseppe; De Spirito, Marco; Fraziano, M; Fadda, Giovanni; Manganelli, R; Delogu, Giovanni
Children and COVID-19: Microbiological and immunological insights
2020-01-01 Buonsenso, D; Sali, M; Pata, D; De Rose, C; Sanguinetti, M; Valentini, P; Delogu, G
Exploiting the mycobacterial cell wall to design improved vaccines against tuberculosis
2013-01-01 Morandi, M; Sali, Michela; Manganelli, R; Delogu, Giovanni
Cysteamine/Cystamine Exert Anti-Mycobacterium abscessus Activity Alone or in Combination with Amikacin
2023-01-01 Palucci, I; Salustri, A; De Maio, F; Pereyra Boza, Mdc; Paglione, F; Sali, M; Occhigrossi, L; D'Eletto, M; Rossin, F; Goletti, D; Sanguinetti, M; Piacentini, M; Delogu, G
Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients
2011-01-01 Fabbiani, Massimiliano; Di Giambenedetto, Simona; Sali, Michela; Farina, Salvatore; Sansonetti, Paola; Tamburrini, Enrica; Verme, Lorenzo Zileri Dal; Delogu, Giovanni; De Luca, Andrea; Kelvin, David; Cauda, Roberto; Fadda, Giovanni
DNA Vaccination against Tuberculosis: Expression of an Ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity
2000-01-01 Delogu, G; A., Howard; Collins, F. M.; And, S. L. MORRIS.
Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin
2004-01-01 Temmerman, S; Pethe, K; Parra, M; Alonso, S; Rouanet, C; Pickett, T; Drowart, A; Debrie, As; Delogu, G; Menozzi, Fd; Sergheraert, C; Brennan, Mj; Mascart, F; Locht, C
Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection
2017-01-01 Chiacchio, T; Delogu, G; Vanini, V; Cuzzi, G; De Maio, F; Pinnetti, C; Sampaolesi, A; Antinori, A; Goletti, D
Low Prevalence of HPV Related Oropharyngeal Carcinogenesis in Northern Sardinia
2022-01-01 Bussu, F; Muresu, N; Crescio, C; Gallus, R; Rizzo, D; Cossu, A; Sechi, I; Fedeli, M; Cossu, A; Delogu, G; Piana, A
Recombinant BCG-Rv1767 amount determines, in vivo, antigen-specific T cells location, frequency, and protective outcome
2010-01-01 Speranza, V; Colone, A; Cicconi, R; Palmieri, G; Giovannini, D; Grassi, M; Mattei, M; Sali, M; Delogu, G; Andreola, F; Colizzi, V; Mariani, F
3D-printed graphene polylactic acid devices resistant to SARS-CoV-2: Sunlight-mediated sterilization of additive manufactured objects
2022-01-01 De Maio, F; Rosa, E; Perini, G; Augello, A; Niccolini, B; Ciaiola, F; Santarelli, G; Sciandra, F; Bozzi, M; Sanguinetti, M; Sali, M; De Spirito, M; Delogu, G; Palmieri, V; Papi, M
Structural Basis of PE_PGRS Polymorphism, a Tool for Functional Modulation
2023-01-01 Kramarska, Eliza; De Maio, Flavio; Delogu, Giovanni; Berisio, Rita
Clinical isolates of the modern Mycobacterium tuberculosis lineage 4 evade host defense in human macrophages through eluding IL-1β-induced autophagy
2018-01-01 Romagnoli, A; Petruccioli, E; Palucci, I; Camassa, S; Carata, E; Petrone, L; Mariano, S; Sali, M; Dini, L; Girardi, E; Delogu, G; Goletti, D; Fimia, Gm
PE_PGRS33 Contributes to Mycobacterium tuberculosis Entry in Macrophages through Interaction with TLR2
2016-01-01 Palucci, I; Camassa, S; Cascioferro, A; Sali, M; Anoosheh, S; Zumbo, A; Minerva, M; Iantomasi, R; De Maio, F; Di Sante, G; Ria, F; Sanguinetti, M; Palù, G; Brennan, Mj; Manganelli, R; Delogu, G
Characterization of gut microbiota in patients with metabolic syndrome candidates for bariatric/metabolic surgery: Preliminary findings of a multi-center prospective study
2021-01-01 De Maio, F; Boru, Ce; Avallone, M; Velotti, N; Bianco, Dm; Capoccia, D; Greco, F; Guarisco, G; Nogara, M; Sanguinetti, M; Verrastro, O; Capaldo, B; Musella, M; Raffaelli, M; Delogu, G; Silecchia, G; Leonetti, F.
Heparin-binding haemagglutinin implicated in extrapulmonary M. tuberculosis dissemination.
2001-01-01 Pethe, K; Alonso, S; Biet, F; Delogu, G; Brennan, Mj; Locht, C; Menozzi, Fd
Neonatal tuberculosis: an experience that teaches
2012-01-01 Romagnoli, C; Riccardi, R; Purcaro, V; Villani, A; Delogu, G; Zuppa, Aa.
Recovering or Persisting: The Immunopathological Features of SARS-CoV-2 Infection in Children. On Behalf Of The Gemelli-Pediatric Covid-Team
2022-01-01 Buonsenso, D; Valentini, P; De Rose, C; Tredicine, M; Pereyra Boza, Mdc; Camponeschi, C; Morello, R; Zampino, G; Brooks, Aes; Rende, M; Ria, F; Sanguinetti, M; Delogu, G; Sali, M; Di Sante, G
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children | 1-gen-2018 | Sali, M; Buonsenso, D; D'Alfonso, P; De Maio, F; Ceccarelli, M; Battah, B; Palucci, I; Chiacchio, T; Goletti, D; Sanguinetti, M; Valentini, P; Delogu, G | |
| Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: a prospective, observational study | 1-gen-2012 | Garcovich, S; Ruggeri, A; D'Agostino, M; Ardito, F; De Simone, C; Delogu, G; Fadda, G. | |
| PE_PGRS30 is required for the full virulence of Mycobacterium tuberculosis | 1-gen-2012 | Iantomasi, Raffaella; Sali, Michela; Cascioferro, A; Palucci, Ivana; Zumbo, Antonella; Soldini, Silvia; Rocca, S; Greco, E; Maulucci, Giuseppe; De Spirito, Marco; Fraziano, M; Fadda, Giovanni; Manganelli, R; Delogu, Giovanni | |
| Children and COVID-19: Microbiological and immunological insights | 1-gen-2020 | Buonsenso, D; Sali, M; Pata, D; De Rose, C; Sanguinetti, M; Valentini, P; Delogu, G | |
| Exploiting the mycobacterial cell wall to design improved vaccines against tuberculosis | 1-gen-2013 | Morandi, M; Sali, Michela; Manganelli, R; Delogu, Giovanni | |
| Cysteamine/Cystamine Exert Anti-Mycobacterium abscessus Activity Alone or in Combination with Amikacin | 1-gen-2023 | Palucci, I; Salustri, A; De Maio, F; Pereyra Boza, Mdc; Paglione, F; Sali, M; Occhigrossi, L; D'Eletto, M; Rossin, F; Goletti, D; Sanguinetti, M; Piacentini, M; Delogu, G | |
| Immune response to influenza A (H1N1)v monovalent MF59-adjuvanted vaccine in HIV-infected patients | 1-gen-2011 | Fabbiani, Massimiliano; Di Giambenedetto, Simona; Sali, Michela; Farina, Salvatore; Sansonetti, Paola; Tamburrini, Enrica; Verme, Lorenzo Zileri Dal; Delogu, Giovanni; De Luca, Andrea; Kelvin, David; Cauda, Roberto; Fadda, Giovanni | |
| DNA Vaccination against Tuberculosis: Expression of an Ubiquitin-conjugated tuberculosis protein enhances antimycobacterial immunity | 1-gen-2000 | Delogu, G; A., Howard; Collins, F. M.; And, S. L. MORRIS. | |
| Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin | 1-gen-2004 | Temmerman, S; Pethe, K; Parra, M; Alonso, S; Rouanet, C; Pickett, T; Drowart, A; Debrie, As; Delogu, G; Menozzi, Fd; Sergheraert, C; Brennan, Mj; Mascart, F; Locht, C | |
| Immune characterization of the HBHA-specific response in Mycobacterium tuberculosis-infected patients with or without HIV infection | 1-gen-2017 | Chiacchio, T; Delogu, G; Vanini, V; Cuzzi, G; De Maio, F; Pinnetti, C; Sampaolesi, A; Antinori, A; Goletti, D | |
| Low Prevalence of HPV Related Oropharyngeal Carcinogenesis in Northern Sardinia | 1-gen-2022 | Bussu, F; Muresu, N; Crescio, C; Gallus, R; Rizzo, D; Cossu, A; Sechi, I; Fedeli, M; Cossu, A; Delogu, G; Piana, A | |
| Recombinant BCG-Rv1767 amount determines, in vivo, antigen-specific T cells location, frequency, and protective outcome | 1-gen-2010 | Speranza, V; Colone, A; Cicconi, R; Palmieri, G; Giovannini, D; Grassi, M; Mattei, M; Sali, M; Delogu, G; Andreola, F; Colizzi, V; Mariani, F | |
| 3D-printed graphene polylactic acid devices resistant to SARS-CoV-2: Sunlight-mediated sterilization of additive manufactured objects | 1-gen-2022 | De Maio, F; Rosa, E; Perini, G; Augello, A; Niccolini, B; Ciaiola, F; Santarelli, G; Sciandra, F; Bozzi, M; Sanguinetti, M; Sali, M; De Spirito, M; Delogu, G; Palmieri, V; Papi, M | |
| Structural Basis of PE_PGRS Polymorphism, a Tool for Functional Modulation | 1-gen-2023 | Kramarska, Eliza; De Maio, Flavio; Delogu, Giovanni; Berisio, Rita | |
| Clinical isolates of the modern Mycobacterium tuberculosis lineage 4 evade host defense in human macrophages through eluding IL-1β-induced autophagy | 1-gen-2018 | Romagnoli, A; Petruccioli, E; Palucci, I; Camassa, S; Carata, E; Petrone, L; Mariano, S; Sali, M; Dini, L; Girardi, E; Delogu, G; Goletti, D; Fimia, Gm | |
| PE_PGRS33 Contributes to Mycobacterium tuberculosis Entry in Macrophages through Interaction with TLR2 | 1-gen-2016 | Palucci, I; Camassa, S; Cascioferro, A; Sali, M; Anoosheh, S; Zumbo, A; Minerva, M; Iantomasi, R; De Maio, F; Di Sante, G; Ria, F; Sanguinetti, M; Palù, G; Brennan, Mj; Manganelli, R; Delogu, G | |
| Characterization of gut microbiota in patients with metabolic syndrome candidates for bariatric/metabolic surgery: Preliminary findings of a multi-center prospective study | 1-gen-2021 | De Maio, F; Boru, Ce; Avallone, M; Velotti, N; Bianco, Dm; Capoccia, D; Greco, F; Guarisco, G; Nogara, M; Sanguinetti, M; Verrastro, O; Capaldo, B; Musella, M; Raffaelli, M; Delogu, G; Silecchia, G; Leonetti, F. | |
| Heparin-binding haemagglutinin implicated in extrapulmonary M. tuberculosis dissemination. | 1-gen-2001 | Pethe, K; Alonso, S; Biet, F; Delogu, G; Brennan, Mj; Locht, C; Menozzi, Fd | |
| Neonatal tuberculosis: an experience that teaches | 1-gen-2012 | Romagnoli, C; Riccardi, R; Purcaro, V; Villani, A; Delogu, G; Zuppa, Aa. | |
| Recovering or Persisting: The Immunopathological Features of SARS-CoV-2 Infection in Children. On Behalf Of The Gemelli-Pediatric Covid-Team | 1-gen-2022 | Buonsenso, D; Valentini, P; De Rose, C; Tredicine, M; Pereyra Boza, Mdc; Camponeschi, C; Morello, R; Zampino, G; Brooks, Aes; Rende, M; Ria, F; Sanguinetti, M; Delogu, G; Sali, M; Di Sante, G |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Articolo su rivista72051
- 2 Contributo in volume (Capitolo ...1
- 7 Altro1
Data di pubblicazione
- In corso di stampa65
- 2020 - 202617130
- 2010 - 201923036
- 2000 - 200918346
- 1990 - 19998891
- 1980 - 19893844
- 1970 - 1979711
- 1965 - 196930
Editore
- MDPI975
- Elsevier Ltd764
- Elsevier B.V.654
- MDPI AG497
- Elsevier394
- John Wiley and Sons Inc331
- Springer323
- Multidisciplinary Digital Publish...309
- Springer Science and Business Med...301
- Elsevier Inc.267
Rivista
- ACTA BIO-MEDICA DE L'ATENEO PARMENSE933
- PLOS ONE384
- ANNALI DELLA FACOLTÀ DI MEDICINA ...348
- SCIENTIFIC REPORTS283
- AREA262
- INTERNATIONAL JOURNAL OF MOLECULA...198
- DOCTOR. OS183
- ACTA BIOMEDICA182
- NUTRIENTS181
- PHYSICAL REVIEW. B, CONDENSED MAT...169
Serie
- KEY ENGINEERING MATERIALS1
Keyword
- Humans2918
- Female1598
- Male1494
- Middle Aged905
- Adult898
- Aged761
- Animals652
- Italy594
- Medicine (all)464
- COVID-19460
Lingua
- eng43627
- ita9146
- fre232
- spa124
- ger102
- und61
- enm49
- rus41
- grc33
- por33
Accesso al fulltext
- no fulltext58732
- reserved8054
- open3775
- partially open822
- restricted667
- embargoed2
- mixed1